BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10566609)

  • 1. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction therapy for non-small cell lung cancer].
    Matsumara A; Mori T
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1826-32. PubMed ID: 11729474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction therapy before surgery for non-small cell lung cancer.
    Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
    Rays; 2004; 29(4):445-52. PubMed ID: 15852734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
    Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer.
    Grossi F; Pennucci MC; Serrano J; Frola C; Mereu C; Scolaro T; Ratto GB; Tixi L; Ardizzoni A
    Anticancer Res; 2002; 22(6B):3519-24. PubMed ID: 12552949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in a multidisciplinary approach to the treatment of stage III non-small-cell bronchial cancers (NSCBC)].
    Milleron B; Depierre A
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):383-95. PubMed ID: 9690309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    Rusch VW; Giroux DJ; Kraut MJ; Crowley J; Hazuka M; Winton T; Johnson DH; Shulman L; Shepherd F; Deschamps C; Livingston RB; Gandara D
    J Clin Oncol; 2007 Jan; 25(3):313-8. PubMed ID: 17235046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemoradiation in non-small cell lung cancer].
    Milleron B; Girard N; Gounant V; Mornex F
    Cancer Radiother; 2007; 11(1-2):36-40. PubMed ID: 17055314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
    Burfeind WR; Harpole DH
    Semin Thorac Cardiovasc Surg; 2005; 17(3):186-90. PubMed ID: 16253820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
    Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
    De Candis D; Stani SC; Bidoli P; Bedini VA; Potepan P; Navarria P; Aglione S; Bajetta E
    Am J Clin Oncol; 2003 Jun; 26(3):265-9. PubMed ID: 12796598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy in non-small cell lung cancer.
    Le Chevalier T
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):62-5. PubMed ID: 9728587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of surgery in N2 non-small cell lung cancer.
    DeCamp MM; Ashiku S; Thurer R
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
    Yamaguchi M; Fukuyama Y; Ichinose Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.